Every component on the airline subsector was up for the day after the major carriers announced intentions to continue the capacity discipline in spite of strong demand.
Some distrust toward blue chips arose after the Dow Jones took a major hit in the massive volatility swings. Many health companies continue to hover toward the bottom of their 52-week range in spite of being a safer bet than the treasury's many investors are chasing.
Airlines have had a tough year and have been the victim of analyst flip flopping on their future. Their close ties with the state of the economy have discouraged buying but some of these look ripe for a contrarian buy.
These three companies appear to have the potential for major upsides either as a result of an upcoming event or a structural change ahead. There are a lot of bargain buys out there right now but not all are created equal. These three look as though they might be the cream of the crop.